Quorum Health receives NYSE continued listing standard notice
Quorum Health Corporation announced that it was notified on December 3, 2019 by the New York Stock Exchange that it was not in compliance with the NYSE's continued listing standards as a result of the average closing price of the company's common stock being less than $1.00 per share over a consecutive 30 trading-day period. As set forth in the December Notice, as of December 3, 2019, the 30 trading-day average closing share price of the company's common stock was 90c. In accordance with the NYSE rules, the company has a period of six months following the receipt of the December Notice to regain compliance with the minimum share price requirement. The company plans to notify the NYSE within 10 business days of its intent to cure the deficiency. The company can regain compliance with the minimum share price requirement at any time during the six month cure period if, on the last trading day of any calendar month during the cure period or on the last day of the cure period, the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on such date.